Zepbound
Tirzepatide
Dual-pathway GLP-1/GIP support for weight management
FDA-approved weight management medication containing tirzepatide for adults with obesity or related health conditions.
About Zepbound
Zepbound® is an FDA-approved tirzepatide medication for chronic weight management. It activates both GIP and GLP-1 receptors, offering a dual-pathway approach to appetite and metabolic support under licensed medical supervision.
Key benefits
- Dual GIP/GLP-1 receptor activity for appetite support
- FDA-approved specifically for weight management
- Structured titration supervised by your clinician
- Integrated with nutrition and lifestyle coaching
Who may qualify
- Adults meeting FDA-outlined BMI and comorbidity criteria
- Full medical history review before prescribing
- Not appropriate for patients with certain thyroid or pancreatic conditions
How treatment works
Clinician assessment
A licensed provider evaluates whether tirzepatide aligns with your health profile and goals.
Personalized titration
Dosing increases gradually to improve tolerance and safety.
Continuous monitoring
Regular check-ins track progress, side effects, and plan adjustments.
Good to know
- GI side effects such as nausea may occur, particularly during titration.
- Your clinician will review thyroid, pancreatic, and cardiovascular history.
- Individual response varies; results are not guaranteed.
GLP-1 medications are available by prescription only after a licensed provider determines eligibility. This information is educational and not medical advice.
Common questions
Both contain tirzepatide, but Zepbound is FDA-approved for weight management while Mounjaro is approved for type 2 diabetes. Your clinician determines the appropriate option for you.
No. Eligibility depends on your medical history, current medications, and clinical judgment from your licensed provider.
Wegovy
Semaglutide
Prescription weight-loss medication for adults with obesity or excess weight and related health conditions.
Ozempic
Semaglutide
GLP-1 prescription medication FDA-approved for type 2 diabetes and prescribed off-label for weight management.
Mounjaro
Tirzepatide
Prescription medication for adults with type 2 diabetes used in personalized provider-supervised care plans.